Navigation Links
A View from Rwanda: Congressional Briefing Highlights Impact of U.S. funded Anti-Malaria Programs
Date:4/23/2009

Rwandan Health Ministry Official shows programs funded by the Global Fund and President's Malaria Initiative help Rwanda reduce malaria deaths by more than 60 percent.

Washington, DC (PRWEB) April 23, 2009 -- At a Congressional briefing held today in advance of World Malaria Day, speakers discussed the current state of malaria in Rwanda and how the country reduced deaths due to the disease by more than 60 percent. The briefing highlighted the crucial role of political commitment of Rwandan leaders, partnerships, community engagement, and U.S. support for the Global Fund to Fight AIDS, TB and Malaria and the U.S. Malaria Programs in making this success possible.

"Over the course of the last several years, Rwanda has reduced the number of children hospitalized due to malaria by more than 60 percent. Through action and partnership, Rwanda has shown that success is truly achievable against malaria," said Dr. Corine Karema, Director of Rwanda's National Malaria Control Program (through TRACPLUS). "We have proven in Rwanda that we can dramatically increase the number of lives saved through funding and implementing programs in malarial countries. Now, we must recognize the opportunity facing not just Rwanda, but the world: for the first time in the history of this disease, we have an opportunity to eliminate the burden of malaria to a point where it is no longer considered a major public health problem. We must keep up the fight to ensure that this promise can become a reality."


Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. TriWest Sponsors Congressional Medal of Honor Convention
2. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
3. Injured Soldiers at Walter Reed Hospital to Benefit From Congressional Fundraiser
4. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
5. Black AIDS Mobilization Gains Momentum with Congressional Black Caucus Call to Action
6. Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access
7. Congressional and Religious Leaders to Urge Over-ride of Presidential SCHIP Veto
8. More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delawares Kids the Healthiest in the Nation
9. AGD Applauds Congressional Support of SCHIP Reauthorization
10. Congressional Support Grows for FDA Regulation of Tobacco: Bill Now Sponsored by 55 Senators, 200 Representatives
11. Capps to Lead Bipartisan Womens Caucus Congressional Delegation to Represent United States at Women Deliver Conference in London

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...Call/ - AIM Health Group Inc. ("AIM" or the "Compa...company, announced today that its net income for t...e "Quarter") increased to $633,199 from $12,319 in...1) increased 290% to $910,734 from $230,862, on a ...nced that revenues increased 87% to $13.1 million ...
(Date:11/30/2009)...act, CBO analysis understates the effect ,, WA... Blue Cross and Blue Shield Association (BCBSA) is...e released today by the Congressional Budget Offic...conomists, actuaries, and health policy experts ha...ll would make coverage more expensive for millions...
(Date:11/30/2009)...than sedentary, healthy adults , , , MO...wn that exercise can help ward off heart disease a...son why may be found within cells themselves. , ...at the tips of chromosomes that protect the cell -...ing adults who did not exercise regularly, German ...
(Date:11/30/2009)...swire-FirstCall/ -- Jedi Mind, Inc . (Pink Sheets...ce the Company,s first thought-controlled game is ...ink-Tac-Toe" is the first of its kind, which allow...r mind and is geared towards people of all ages. T...can be purchased directly through the Company by c...
(Date:11/30/2009)...re/ -- Of the more than one million people in the ... half are African American. Moreover, the HIV/AIDS...d the threshold for a severe epidemic three times ...ent of all women infected with the virus in the na....*, World AIDS Day, BET shines a light on these al...
Breaking Medicine News(10 mins):Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3
... A single tumor-suppressing gene is a key to unde...ncer cells that persist after initial treatment on...versity of Texas M. D. Anderson Cancer Center repo...f-cannibalization, in ovarian cancer cells. Often...
...t of its kind study, a first-degree family history... outcomes of prostate cancer patients treated with...tients with this type of family history have clini...tion Oncology*Biology*Physics , the official journ...
...rs at the University Of Southern California, Schoo...at links oral bisphosphonates to increased jaw nec... that even short-term use of common oral osteoporo...ociation ( JADA ). , Osteoporosis currently affe...
... MD (Jan. 1, 2009) Antioxidant supplementation wa...cing levels of oxidative stress in patients with c...Gastroenterology . CP is a progressive inflammator...r problem in 90 percent of patients with CP and cu...
...Mass.Everybody is familiar with the stereotypes of...rueling hours, little recognition, and even less g...demic Medicine this month pulls back the curtain ... raises questions about how the prevailing culture...
...t lead to new treatment for blood cancers, researc... News) -- More than three-quarters of laboratory l...ds died within 24 hours, effectively killing thems...tein that regulates the cell-signaling pathway the...
Other Medicine News:Health News:Dormant cancer cells rely on cellular self-cannibalization to survive 2Health News:Family history of prostate cancer does not affect some treatment outcomes 2Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:Antioxidants offer pain relief in patients with chronic pancreatitis 2Health News:The culture of medicine 2Health News:Grape Seed Extract Kills Leukemia Cells in Lab 2
(Date:11/30/2009)...LOS, Calif., Nov. 30 Nek...the promotion of Lorianne Masuoka, M.D. to Senior ...uoka will report directly to Nektar,s President an..., "Lorianne,s outstanding leadership and highly ef...instrumental in rapidly advancing Nektar,s proprie...
(Date:11/30/2009)...L, Wash., Nov. 30 SCOLR ...at on November 25, 2009, the NYSE Amex LLC (the "E...d the Company,s plan to comply with its previously...)(iv) of the Exchange Company Guide. Specifically...stained losses which were so substantial in relati...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Cardiac Defibrillat..., http://www.reportlinker.com/p0164315/Cardiac-De...ort.html ,, Cardiovascular disease (CVD) is o...den cardiac arrest survivors are prone to arrhythm...
Breaking Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Early detection of osteoarthritis in dogs could open doors for a cure 48474 1Early detection of osteoarthritis in dogs could open doors for a cure 48474 2Legislation Will Expand Access to Life Saving Laboratory Tests 48470 1Legislation Will Expand Access to Life Saving Laboratory Tests 48470 2Beetle shell inspires brilliant white paper 8787 1Beetle shell inspires brilliant white paper 8787 2Beetle shell inspires brilliant white paper 8787 3
... Immunosyn,Corporation (OTC Bulletin Board: IMYN) ...dies Summary (CFR 312.36). The Institute of Biolo...logies, LLC, Immunosyn,s largest shareholder, to c...1019 on several progressive neurological,auto-immu... no satisfactory,form of therapy. The studies were...
...udy highlight significant improvements in RA symp... ACTEMRA that specifically targets int...a from two pivotal,multinational Phase III clinica...ocilizumab) significantly improved the signs and s...failed to adequately respond to,anti-rheumatic the...
Other Medicine Technology:Immunosyn Corporation Releases SF-1019 Study Results 2Immunosyn Corporation Releases SF-1019 Study Results 3Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 2Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 3Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 4Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 5Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 6
1 mL Disposable Tips
Finntip 1000
Disposable Tips, 1100 l (960)
Disposable Tips, 300 l (960)
Medicine Products: